Conclusion: Building Resilience Current evidence indicates that detoxification constitutes a continuous, enzyme-mediated metabolic process rather than a sporadic or episodic event
This projection is supported by the broad utility of GLP-1 medications, which not only are effective for weight loss but also improve a range of comorbid conditions associated with obesity, including heart failure, chronic kidney disease, sleep apnea, and fatty liver disease
Maybe not so much
67,74,75,76,77,78 Interactions of the suppressor/enhancer of lin12-like (SEL1L) with several chaperones, including BiP, homoCys-responsive ER-resident protein (HERP), OS9, XTP3B (endoplasmic reticulum lectin 1 (ERLEC1)), PDI, EDEMs, and ERdj5, have been implicated in substrate recognition
Oral formulations Moving beyond injections Historically, GLP-1 drugs have been injectable because peptides are broken down in the digestive tract before they can be absorbed